Although the exact role of TET2 mutations and which genes and pathways it regulates is not fully understood in AML, in vitro studies and animal models suggest that loss of catalytic function of TET2 may contribute to leukemogenesis due to disruption of the cell renewal control, but its sole mutations are insufficient to induce AML [112, 152]. Here, TET2 is linked to acute myeloid leukemia.